论文部分内容阅读
目的:探究2型糖尿病应用甘舒霖30R、阿卡波糖联合治疗的临床效果。方法:选取60例我院在2013年6月至2014年12月收治的2型糖尿病患者,将其随机分为30例对照组与30例观察组。其中,给予对照组患者单纯的甘舒霖30R治疗,给予观察组患者甘舒霖30R、阿卡波糖联合治疗。最后观察两组患者的临床状况。结果:治疗后,两组患者的空腹血糖(FPG)、糖化血红蛋白(Hb A1C)、餐后2h血糖(2h PG)水平均明显降低,且观察组2h PG水平明显低于对照组(P<0.05)。结论:2型糖尿病应用甘舒霖30R、阿卡波糖联合治疗,可取得满意的治疗效果,治疗安全可靠,具有较高的临床利用价值。
Objective: To investigate the clinical effect of combined application of Gansu Lin 30R and acarbose in type 2 diabetes mellitus. Methods: Sixty patients with type 2 diabetes admitted from June 2013 to December 2014 in our hospital were randomly divided into 30 control groups and 30 observation groups. Among them, patients in the control group were treated with Gansu Lin 30R alone, and patients in the observation group were given Gansu Lin 30R combined with acarbose. Finally observe the clinical status of two groups of patients. Results: After treatment, fasting plasma glucose (FPG), Hb A1C, and 2h postprandial blood glucose (2h PG) were significantly decreased in both groups, and PG levels in observation group were significantly lower than those in control group (P <0.05 ). Conclusion: Gan Shu-lin 30R and acarbose combined with treatment of type 2 diabetes can achieve satisfactory therapeutic effect, which is safe and reliable and has high clinical value.